홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
ELVN
#1719
Enliven Therapeutics, Inc. Common Stock
29.690
0
+2.63%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+2.63%
월간 변동
+13.58%
6달 변화
+43.71%
년간 변동율
+43.71%
이전 종가
28.930
0
Open
29.700
0
Bid
Ask
Low
29.690
0
High
29.700
0
양
140
마켓
주식
헬스케어
ELVN
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
48.86 M
49 M
49.07 M
59.24 M
59.35 M
—
Valuation ratios
Enterprise value
1.15 B
978.48 M
863.98 M
1.07 B
1.11 B
4.02 B
Price to earnings ratio
-14.85
-11.9
-10.25
-10.03
-11.13
-43.31
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
16.12
14.47
12.9
14.05
14.74
56.17
Price to book ratio
0.95
3.42
0.8
0.72
0.7
5.64
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.08
0.07
0.09
0.05
0.04
0.26
Return on equity %
0.08
0.07
0.1
0.05
0.04
0.27
Return on invested capital %
464.56
586.3
737.43
637.98
575.25
2 536.97
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
17.44
19.99
21.06
32.58
32.95
106.58
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.25
0.37
0.48
0.33
0.21
1.39
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
6.05
6.66
5.79
9.41
7.69
29.55
Net current asset value per share
6.15
6.76
5.88
9.51
7.77
29.92
Tangible book value per share
5.98
6.58
5.76
9.37
7.67
29.38
Working capital per share
5.8
6.42
5.6
9.22
7.54
28.78
Book value per share
5.98
6.58
5.76
9.37
7.67
29.38
뉴스
Heyman, Enliven Therapeutics 이사, 3.2만 달러 상당 주식 매도
Heyman, Enliven Therapeutics director, sells $32k in stock
리시카토스, 엔라이븐 테라퓨틱스 CSO, 14.5만 달러 상당 주식 매도
Lyssikatos, Enliven Therapeutics CSO, sells $145k in shares
Lyssikatos, Enliven Therapeutics CSO, sells $535k in ELVN stock
Enliven Therapeutics 이사 Heyman, 32,901달러 상당 주식 매도
Enliven Therapeutics director Heyman sells $32,901 in stock
Anish Patel, COO of Enliven Therapeutics, sells $1.35m in ELVN
Enliven Therapeutics: Springing Into 2026 With Data, But I'm Still Cautious
Enliven Therapeutics CSO, 347만 달러 상당 주식 매도
Enliven Therapeutics CSO Lyssikatos sells $3.47 million in shares
Enliven Therapeutics, 52주 신고가 $25.64 기록